A citation-based method for searching scientific literature

Jingya Yu, Xiaotian Yuan, Louise Sjöholm, Tiantian Liu, Feng Kong, Tomas J Ekström, Magnus Björkholm, Dawei Xu. Cancer Lett 2018
Times Cited: 24







List of co-cited articles
253 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Z Liu, Q Li, K Li, L Chen, W Li, M Hou, T Liu, J Yang, C Lindvall, M Björkholm,[...]. Oncogene 2013
176
50


Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
37

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
37

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
37



Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
294
33


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
222
33

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
103
29

WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells.
Kai Zhang, Yanjing Guo, Xue Wang, Huifang Zhao, Zhongzhong Ji, Chaping Cheng, Li Li, Yuxiang Fang, Dawei Xu, Helen He Zhu,[...]. Cancer Res 2017
74
29

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
21
33

hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor.
Ning Liu, Deqiang Ding, Wanyu Hao, Fan Yang, Xiaoying Wu, Miao Wang, Xiaoling Xu, Zhenyu Ju, Jun-Ping Liu, Zhangfa Song,[...]. Nucleic Acids Res 2016
46
29

Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
437
29

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
382
25


The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Xiaotian Yuan, Guanghui Cheng, Jingya Yu, Shunzhen Zheng, Chao Sun, Qing Sun, Kailin Li, Zhaomin Lin, Tiantian Liu, Ping Li,[...]. Oncotarget 2017
20
30

MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.
Xiaolu Zhang, Bingnan Li, Jingya Yu, Jenny Dahlström, Anh Nhi Tran, Magnus Björkholm, Dawei Xu. Ann Hematol 2018
14
42

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
200
25

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
278
25

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
258
25

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Donghyun D Lee, Ricardo Leão, Martin Komosa, Marco Gallo, Cindy H Zhang, Tatiana Lipman, Marc Remke, Abolfazl Heidari, Nuno Miguel Nunes, Joana D Apolónio,[...]. J Clin Invest 2019
49
25

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Andrew Mancini, Ana Xavier-Magalhães, Wendy S Woods, Kien-Thiet Nguyen, Alexandra M Amen, Josie L Hayes, Christof Fellmann, Michael Gapinske, Andrew M McKinney, Chibo Hong,[...]. Cancer Cell 2018
46
25

Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
Wanil Kim, Andrew T Ludlow, Jaewon Min, Jerome D Robin, Guido Stadler, Ilgen Mender, Tsung-Po Lai, Ning Zhang, Woodring E Wright, Jerry W Shay. PLoS Biol 2016
83
25

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
258
20

The ETS family of oncogenic transcription factors in solid tumours.
Gina M Sizemore, Jason R Pitarresi, Subhasree Balakrishnan, Michael C Ostrowski. Nat Rev Cancer 2017
111
20

TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
Jenny Dahlström, Tiantian Liu, Xiaotian Yuan, Leonie Saft, Mehran Ghaderi, Ya Bin Wei, Catharina Lavebratt, Ping Li, Chengyun Zheng, Magnus Björkholm,[...]. Ann Hematol 2016
17
29

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
21
23

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.
Chong Li, Song Wu, Haifeng Wang, Xingang Bi, Zhao Yang, Ying Du, Luyun He, Zhiming Cai, Jiansong Wang, Zusen Fan. Oncotarget 2015
28
20


Myc activates telomerase.
J Wang, L Y Xie, S Allan, D Beach, G J Hannon. Genes Dev 1998
534
20

Alternative splicing regulation of telomerase: a new paradigm?
Mandy S Wong, Woodring E Wright, Jerry W Shay. Trends Genet 2014
60
20

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Yanxia Guo, Xiaotian Yuan, Kailin Li, Mingkai Dai, Lu Zhang, Yujiao Wu, Chao Sun, Yuan Chen, Guanghui Cheng, Cheng Liu,[...]. Cell Death Differ 2020
14
35

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.
Kun Wang, Tiantian Liu, Nan Ge, Li Liu, Xiaotian Yuan, Jikai Liu, Feng Kong, Chang Wang, Hongbo Ren, Keqiang Yan,[...]. Oncotarget 2014
41
20

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
16

GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Sheng Zhang, Kang Zhang, Piyou Ji, Xuqing Zheng, Jianbin Jin, Min Feng, Pingguo Liu. BMC Cancer 2017
12
33


TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
Kun Wang, Tiantian Liu, Li Liu, Jikai Liu, Cheng Liu, Chang Wang, Nan Ge, Hongbo Ren, Keqiang Yan, Sanyuan Hu,[...]. Oncotarget 2014
49
16

Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Yidong Fan, Zhaoxu Liu, Xiaolei Fang, Zheng Ge, Nan Ge, Yong Jia, Peng Sun, Fenglan Lou, Magnus Björkholm, Astrid Gruber,[...]. Clin Cancer Res 2005
44
16

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
150
16

Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Taiji Ito, Hirotaka Watanabe, Nobutake Yamamichi, Shunsuke Kondo, Toshio Tando, Takeshi Haraguchi, Taketoshi Mizutani, Kouhei Sakurai, Shuji Fujita, Tomonori Izumi,[...]. Biochem J 2008
31
16


TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
194
16

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.
Katrin Hoffmeyer, Angelo Raggioli, Stefan Rudloff, Roman Anton, Andreas Hierholzer, Ignacio Del Valle, Kerstin Hein, Riana Vogt, Rolf Kemler. Science 2012
349
16

TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.
Li Liu, Cheng Liu, Omid Fotouhi, Yidong Fan, Kun Wang, Chuanyou Xia, Benkang Shi, Guangyong Zhang, Kexin Wang, Feng Kong,[...]. Oncologist 2017
8
50


Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen, Xiao Liu, Yingrui Li, Nikki P Lee, Wah H Lee, Pramila N Ariyaratne, Chandana Tennakoon,[...]. Nat Genet 2012
553
16

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.
D Xu, N Popov, M Hou, Q Wang, M Björkholm, A Gruber, A R Menkel, M Henriksson. Proc Natl Acad Sci U S A 2001
251
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.